WO2011085645A1 - Solution de sucralose et son procédé de fabrication - Google Patents
Solution de sucralose et son procédé de fabrication Download PDFInfo
- Publication number
- WO2011085645A1 WO2011085645A1 PCT/CN2011/000075 CN2011000075W WO2011085645A1 WO 2011085645 A1 WO2011085645 A1 WO 2011085645A1 CN 2011000075 W CN2011000075 W CN 2011000075W WO 2011085645 A1 WO2011085645 A1 WO 2011085645A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- sodium
- weight
- potassium
- solution
- Prior art date
Links
- 239000004376 Sucralose Substances 0.000 title claims abstract description 64
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 title claims abstract description 64
- 235000019408 sucralose Nutrition 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000003755 preservative agent Substances 0.000 claims abstract description 24
- 239000001488 sodium phosphate Substances 0.000 claims abstract description 15
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 239000003381 stabilizer Substances 0.000 claims abstract description 12
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 11
- 230000002335 preservative effect Effects 0.000 claims abstract description 10
- 229910000162 sodium phosphate Inorganic materials 0.000 claims abstract description 9
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims abstract description 5
- 235000019799 monosodium phosphate Nutrition 0.000 claims abstract description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims abstract description 4
- 235000019832 sodium triphosphate Nutrition 0.000 claims abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 87
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 45
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 44
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 44
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 229910019142 PO4 Inorganic materials 0.000 claims description 29
- 235000021317 phosphate Nutrition 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 23
- 239000004471 Glycine Substances 0.000 claims description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 22
- 239000004310 lactic acid Substances 0.000 claims description 22
- 235000014655 lactic acid Nutrition 0.000 claims description 22
- 239000010452 phosphate Substances 0.000 claims description 22
- 235000015424 sodium Nutrition 0.000 claims description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 20
- 239000001530 fumaric acid Substances 0.000 claims description 20
- 239000001632 sodium acetate Substances 0.000 claims description 20
- 235000017281 sodium acetate Nutrition 0.000 claims description 20
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- 239000008213 purified water Substances 0.000 claims description 17
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- 108010039918 Polylysine Proteins 0.000 claims description 16
- 229920000656 polylysine Polymers 0.000 claims description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 claims description 15
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 13
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 13
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 12
- 239000000920 calcium hydroxide Substances 0.000 claims description 12
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 12
- 239000011591 potassium Substances 0.000 claims description 12
- 229960003975 potassium Drugs 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 235000013343 vitamin Nutrition 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 claims description 10
- 229940024606 amino acid Drugs 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 239000001508 potassium citrate Substances 0.000 claims description 10
- 229960002635 potassium citrate Drugs 0.000 claims description 10
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 10
- 235000011082 potassium citrates Nutrition 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 9
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 9
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 9
- 239000011975 tartaric acid Substances 0.000 claims description 9
- 235000002906 tartaric acid Nutrition 0.000 claims description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 9
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 claims description 8
- 239000001521 potassium lactate Substances 0.000 claims description 8
- 235000011085 potassium lactate Nutrition 0.000 claims description 8
- 229960001304 potassium lactate Drugs 0.000 claims description 8
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 8
- 239000001509 sodium citrate Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 7
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 6
- 239000001354 calcium citrate Substances 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 235000019264 food flavour enhancer Nutrition 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 6
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 239000004267 EU approved acidity regulator Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- -1 For example Chemical compound 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 2
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229930182827 D-tryptophan Natural products 0.000 claims description 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- 241000241413 Propolis Species 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- 150000004056 anthraquinones Chemical class 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 229940061631 citric acid acetate Drugs 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 229940069949 propolis Drugs 0.000 claims description 2
- 229940026314 red yeast rice Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229940073490 sodium glutamate Drugs 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 159000000007 calcium salts Chemical class 0.000 claims 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 239000004097 EU approved flavor enhancer Substances 0.000 claims 1
- 229940045110 chitosan Drugs 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- BDRTVPCFKSUHCJ-UHFFFAOYSA-N molecular hydrogen;potassium Chemical compound [K].[H][H] BDRTVPCFKSUHCJ-UHFFFAOYSA-N 0.000 claims 1
- NFIYTPYOYDDLGO-UHFFFAOYSA-N phosphoric acid;sodium Chemical compound [Na].OP(O)(O)=O NFIYTPYOYDDLGO-UHFFFAOYSA-N 0.000 claims 1
- 229910001950 potassium oxide Inorganic materials 0.000 claims 1
- 235000019983 sodium metaphosphate Nutrition 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 238000002845 discoloration Methods 0.000 abstract description 4
- 230000007062 hydrolysis Effects 0.000 abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 4
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 abstract description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 abstract description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 abstract description 2
- 235000011008 sodium phosphates Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 63
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 238000013112 stability test Methods 0.000 description 15
- 239000004311 natamycin Substances 0.000 description 7
- 235000010298 natamycin Nutrition 0.000 description 7
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 7
- 229960003255 natamycin Drugs 0.000 description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 6
- 229930003571 Vitamin B5 Natural products 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 6
- 229960002079 calcium pantothenate Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 235000009492 vitamin B5 Nutrition 0.000 description 6
- 239000011675 vitamin B5 Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CFOCOVNPZDVGDV-UHFFFAOYSA-N 3,4,5-trihydroxy-2-methylbenzoic acid Chemical compound CC1=C(O)C(O)=C(O)C=C1C(O)=O CFOCOVNPZDVGDV-UHFFFAOYSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000000940 FEMA 2235 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HOAKDRHIAARPFN-UHFFFAOYSA-K [Na+].[Na+].[Na+].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O Chemical compound [Na+].[Na+].[Na+].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HOAKDRHIAARPFN-UHFFFAOYSA-K 0.000 description 1
- WTHXTWHYLIZJBH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTHXTWHYLIZJBH-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- FWLDMXKWEOLCPB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate acetate Chemical compound C(C)(=O)[O-].[Na+].C(CCC(=O)O)(=O)[O-].[Na+] FWLDMXKWEOLCPB-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 239000001476 sodium potassium tartrate Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/37—Halogenated sugars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a functional sweetener and a preparation method thereof, and in particular to a sucralose solution and a preparation method thereof. Background technique
- Sucralose is currently the only functional sweetener produced from sucrose. Its sweetness is 600 times that of sucrose, and its sweetness is pure. It has no bitter aftertaste, no calories, no caries, is obesity, cardiovascular Ideal food additive for sick and diabetic patients. Long-term toxicological tests have shown that sucralose is extremely safe, and environmental studies have further confirmed that this sucralose sweetener is harmless to fish and aquatic organisms and biodegradable. Sucralose is currently widely used in the beverage, food, pharmaceutical, health care and cosmetics industries.
- Sucralose has good stability, especially its aqueous solution is more stable than the solid form, and it is more stable under neutral and acidic conditions.
- the sucralose solution has better dispersion and better adjustability than its solid form. Therefore, the sucralose solution can be used not only in beverages, baked goods, jelly, fruit sugar, etc. in the food industry, but also in medicines, nutraceuticals, cough drops and the like.
- buffer systems may consist of a weak acid and a corresponding weak acid salt, or may be composed of two weak acid salts.
- Suitable buffer systems listed include citric acid with sodium citrate or potassium citrate; phosphoric acid with sodium or potassium phosphate; amino acids with their corresponding salts, such as arginine and arginine HC1, lysine Acid and lysine HC1; tartaric acid and sodium tartrate or potassium tartrate; fatty acid and fatty acid sodium or fatty acid methyl ester; malic acid and sodium malate or potassium palmitate; sodium dihydrogen phosphate and sodium hydrogen phosphate; and other similar substances.
- the solvent used is water, ethanol or propylene Alcohol.
- Chinese Patent 20071016244.5 provides an aqueous solution of sucralose and a preparation method thereof.
- the aqueous solution composition includes one or more of sucralose, a flavoring agent, a preservative, a food coloring matter, a vitamin, a trace element, and an acidity adjusting agent.
- the flavoring agents mentioned in the invention include flavors and fragrances; preservatives include benzoic acid and its salts, sorbic acid and its salts; food colorings include natural and synthetic pigments such as lemon yellow and caramel color; Vitamin AE, vitamin B1-B6; trace elements include calcium, iron, zinc, iodine, selenium; acidity regulators include citrate; water is tap water, distilled water, mineral water, purified water. This invention does not require the pH of the aqueous solution.
- the object of the present invention is to overcome the above disadvantages of the prior art and to provide a sucralose solution which exhibits more excellent stability, can more effectively avoid solution discoloration and hydrolysis problems, and has very good corrosion resistance. Avoid the breeding of harmful microorganisms.
- a sucralose solution comprising sucralose, a preservative, a stabilizer and a solvent, and having a pH of 3.0 to 8.0, preferably 4.0 to 7.5, wherein the stabilizer is selected from the group consisting of trisodium phosphate and hexametaphosphate One or more of sodium, sodium tripolyphosphate, disodium hydrogen phosphate, and sodium dihydrogen phosphate.
- the present inventors have found that the use of these stabilizers in a sucralose solution has the effect of retaining moisture, making the solution more stable during storage.
- the preservative may be selected from natural preservatives such as tea polyphenols, essential oils, allicin, anthraquinones and propolis; biological preservatives such as polylysine, natamycin, lactobacillus, shells One or more of a glycan, lysozyme, red yeast rice, an antimicrobial peptide, and kojic acid.
- natural preservatives such as tea polyphenols, essential oils, allicin, anthraquinones and propolis
- biological preservatives such as polylysine, natamycin, lactobacillus, shells
- glycan, lysozyme a glycan, lysozyme, red yeast rice, an antimicrobial peptide, and kojic acid.
- the solvent may be selected from water, such as drinking water, deionized water, mineral water, and Purified water; ethanol, such as one or more of food grade ethanol and medicinal ethanol.
- the above solution may further comprise one or more groups of acidity regulators selected from the group consisting of: tartaric acid and calcium hydroxide; tartaric acid and sodium acetate; tartaric acid and disodium succinate; tartaric acid and phosphates such as sodium, potassium or calcium.
- acidity regulators selected from the group consisting of: tartaric acid and calcium hydroxide; tartaric acid and sodium acetate; tartaric acid and disodium succinate; tartaric acid and phosphates such as sodium, potassium or calcium.
- sodium, potassium or calcium orthophosphates, acid phosphates or basic phosphates acetic acid and sodium hydroxide; acetic acid and potassium hydroxide; acetic acid and calcium hydroxide; acetic acid and sodium acetate; acetic acid and disodium succinate
- Acetic acid and citrate such as potassium citrate, sodium or calcium citrate; acetic acid and potassium lactate; acetic acid and phosphate, such as sodium, potassium or calcium orthophosphate, acid phosphate or basic phosphate; Acetic acid and sodium bicarbonate; acetic acid and sodium carbonate; acetic acid and potassium carbonate; fumaric acid and sodium hydroxide; fumaric acid and potassium hydroxide; fumaric acid and calcium hydroxide; fumaric acid and sodium sodium
- the above solution may further comprise a flavor enhancer such as one or more of glycine, disodium succinate, sodium glutamate and L-alanine.
- a flavor enhancer such as one or more of glycine, disodium succinate, sodium glutamate and L-alanine.
- the flavor enhancer maintains a good mouthfeel of the aqueous solution of sucralose.
- the above solution may further comprise a supplementary amino acid selected from one or more of glycine, lysine, arginine and D-tryptophan. Supplementation of amino acids can increase the nutrient of the solution, while some amino acids have certain antiseptic and taste-improving effects.
- the above solution may further comprise one or more of a vitamin such as a water-soluble vitamin Br ⁇ B choline, inositol and vitamin C. Vitamins can be added as appropriate.
- a vitamin such as a water-soluble vitamin Br ⁇ B choline, inositol and vitamin C. Vitamins can be added as appropriate.
- the solution may comprise 3.0% by weight to 35.0% by weight of sucralose; 0.001% by weight to 3.0% by weight, preferably 0.001%, based on the total weight of the solution. Weight) ⁇ 0.5% by weight of preservative; 0.001% by weight ⁇ 3.0% by weight, excellent Choose from 0.001% by weight to 0.5% by weight of stabilizer.
- the solution may further comprise 0.001% by weight to 3.0% by weight, preferably 0.001% by weight to 0.5% by weight, based on the total weight of the solution; % (by weight) ⁇ 3.0% by weight, preferably 0.001% by weight to 0.5% by weight of odorant; 0.001% by weight to 3,0% by weight, preferably 0.001% by weight - 0.5% by weight of supplemental amino acids; 0.001% by weight - 3.0% by weight, preferably 0.001% by weight to 0.5% by weight of vitamins.
- the invention also provides a preparation method of the above solution, the preparation method comprises the following steps: (1) dissolving sucralose in a solvent and decolorizing by adding activated carbon;
- the above preparation method may include the following steps:
- the present invention produces a clear, odorless, colorless, stable, antiseptic sucralose solution by the combination of the above components, which exhibits superior stability compared to the existing sucralose solution product. It can effectively avoid the problem of discoloration and hydrolysis of the solution, and has very good anti-corrosion ability, can avoid the breeding of harmful microorganisms, and can be widely used in food, medicine, health care products and other industries.
- Preparation method The solvent is heated in a suitable container, and after the temperature reaches 45 ° C - 60 ° C, crystal sucralose is added and stirred for 30 minutes.
- a small amount of activated carbon may be added to remove the color, and the activated carbon may be removed by filtration.
- the preservative, acidity regulator, stabilizer, flavor enhancer, amino acid and vitamin are added in sequence according to the steps, stirred for 30 minutes, filtered with a 0.45 micron microporous filter to obtain a filtrate, and finally packaged by ultraviolet sterilization. product.
- Example 1 sucralose 50.00 g, purified water 150.00 g, polylysine 0.02 g, natamycin 0.01 g, acetic acid 0.04 g, sodium acetate 0.04 g, glycine 0.2 g, trisodium phosphate 0.02 g, vitamin B5 0.02g.
- Solution pH 5.0 clear, colorless. After six months of accelerated stability test, the solution was clear, slightly yellow, sucralose content 24.90%, pH 4.2, total colony ⁇ 10 cfb/ml, mold, yeast total ⁇ 10 cfu/ml, and coliform was negative.
- Example 2 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.2 g of acetic acid, 0.2 g of sodium acetate, 0.2 g of glycine, 0.22 g of trisodium phosphate, and 0.04 g of vitamin B5.
- Solution pH 4.9 clear, colorless. After six months of accelerated stability test, the solution was clear, colorless, sucralose content 24.97%, pH 4.2, total colony ⁇ 10 cf / ml, mold, yeast total ⁇ 10 cfu / ml, coliform was negative.
- Example 3 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.01 g of natamycin, 0.02 g of acetic acid, 0.04 g of sodium acetate, 0.2 g of glycine, and 0.02 g of trisodium phosphate.
- Solution pH 5.5 clear, colorless. After six months of accelerated stability test, the solution was clear, colorless, sucralose content 25.05%, pH 4.8, total colony ⁇ 10 cfu/ml, mold, yeast total ⁇ 10 cfu/ml, and coliform was negative.
- Example 4 sucralose 50.00 g, purified water 150.00 g, polylysine 0.02 g, natamycin 0.01 g, acetic acid 0.02 g, disodium succinate 0.04 g, glycine 0.2 g, sodium hexametaphosphate 0.01 g .
- Solution pH 5.6 clear, colorless. After six months of accelerated stability test, the solution was clear and colorless. 3. The chlorosucrose content was 25.02%, the pH was 4.7, the total number of colonies was ⁇ 10 cfu/ml, the total number of molds and yeasts was ⁇ 10 cfu/ml, and the coliform group was negative.
- Example 5 sucralose 50.00 g, purified water 150.00 g, polylysine 0.02 g, natamycin 0.01 g, citric acid 0.04 g, disodium hydrogen phosphate 0.06 g, glycine 0.2 g, trisodium phosphate 0.06 g.
- Solution pH 7.0 clear, colorless. After six months of accelerated stability test, the solution was clear, colorless, sucralose content 24.95%, pH 6.1, total colony ⁇ 10 cfu/ml, mold, yeast total ⁇ 10 cfu/ml, and coliform was negative.
- Example 6 sucralose 50.00 g, purified water 150.00 g, polylysine 0.02 g, natamycin 0.01 g, citric acid 0.03 g, sodium acetate 0.04 g, disodium hydrogen phosphate 0.07 g, glycine 0.2 g, Trisodium phosphate 0.06 g.
- Solution pH 6.7 clear, colorless. After six months of accelerated stability test, dissolve The solution is clear, colorless, sucralose content 24.93%, pH 5.8, total colony ⁇ 10 cfu/ml, mold, yeast total ⁇ 10 cfli/ml, and coliform is negative.
- Example 7 sucralose 50.00 g, purified water 150.00 g, polylysine 0.02 g, natamycin 0.01 g, citric acid 0.03 g, acetic acid 0.02 g, sodium acetate 0.04 g, disodium hydrogen phosphate 0.07 g, 0.2 g of glycine and 0.06 g of trisodium phosphate.
- Example 8 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.03 g of citric acid, 0.07 g of disodium hydrogen phosphate, 0.2 g of glycine, 0.02 g of trisodium phosphate, and 0.04 g of vitamin B5.
- Solution pH 5.7 clear, colorless. After six months of accelerated stability test, the solution was clear and slightly yellow, the sucralose content was 24.92%, pH 5.0, the total number of colonies was ⁇ 10 cfu/ml, the total number of molds and yeasts was ⁇ 10 cfu/ml, and the coliform group was negative.
- Example 9 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.18 g of potassium dihydrogenate, 0.04 g of disodium hydrogen phosphate, 0.2 g of glycine, and 0.04 g of vitamin B5.
- Example 10 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.18 g of potassium dihydrogen phosphate, 0.02 g of disodium hydrogen phosphate, 0.2 g of glycine, 0.01 g of trisodium phosphate, 0.04 g of vitamin B5. .
- Example 11 50.00 g of sucralose, 150.00 g of purified water, 0.02 g of polylysine, 0.04 g of acetic acid, 0.04 g of disodium succinate, 0.2 g of glycine, 0.04 g of vitamin B5, and 0.02 g of trisodium phosphate.
- Solution pH 4.8 clear, colorless. After six months of accelerated stability test, the solution was slightly yellow, the sucralose content was 25.1%, the pH was 4.2, the total number of colonies was ⁇ 10 cf /ml, the total number of molds and yeasts was ⁇ 10 cfu/ml, and the coliform group was negative.
- Example 12 20.00 g of sucralose, 180.00 g of purified water, 0.02 g of polylysine, 0.04 g of acetic acid, 0.06 g of sodium acetate, 0.2 g of glycine, and 0.02 g of trisodium phosphate.
- Solution pH 5.2 clear, colorless. After six months of accelerated stability test, the solution was colorless, sucralose content 9.91%, pH 4.8, total colony ⁇ 10 cfli/ml, mold, yeast total ⁇ 10 cfU/ml, and coliform was negative.
- Example 13 7.00 g of sucralose, 193.00 g of purified water, 0.02 g of polylysine, 0.04 g of acetic acid, 0.06 g of sodium acetate, 0.2 g of glycine, and 0.02 g of trisodium phosphate.
- Solution pH 5.1 clear, colorless; after six months accelerated stability test, the solution is slightly yellow, sucralose content is 3.49%, pH 4.5, total number of colonies ⁇ 10 cfb/ml, total number of molds and yeasts ⁇ 10 cfU/ml
- the coliform group was negative.
- Example 14 50.00 g of sucralose, 50.00 g of purified water, 100.00 g of edible alcohol, 0.02 g of polylysine, 0.04 g of acetic acid, 0.06 g of sodium acetate, 0.2 g of glycine, and 0.02 g of trisodium stearate.
- Solution pH 5.2 clear, colorless; after six months accelerated stability test, the solution is slightly yellow, sucralose content 3.49%, pH 4.6, total number of colonies ⁇ 10 cfu/ml, mold, total yeast ⁇ 10 cf / ml
- the coliform group was negative.
- the results show that the appearance of the above solution is basically colorless transparent liquid, the physical and chemical indicators are basically stable, microorganisms
- the indicators meet the relevant hygiene requirements, the specific test results of the total number of bacteria: ⁇ 10cfu / ml, mold, yeast: ⁇ 10cf / ml, coliform was negative, not detected. Based on this result, it is inferred that the solution has good long-term stability.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
L'invention concerne une solution de sucralose et son procédé de fabrication. La solution comprend du sucralose, un agent conservateur, un agent stabilisateur est un solvant, avec des fourchettes de pH compris entre 3,0 et 8,0. Ledit agent stabilisateur peut être pris parmi un ou plusieurs des composés du groupe suivant : phosphate de sodium, hexamétaphosphate de sodium, tripolyphosphate de sodium, hydrogénophosphate de disodium et hydrogénophosphate de trisodium. Dotée d'une grande stabilité et d'un grand pouvoir de conservation, cette solution de sucralose ne présente pas de risque d'altération de couleur et d'hydrolyse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010002270A CN101744216A (zh) | 2010-01-18 | 2010-01-18 | 一种三氯蔗糖溶液及其制备方法 |
CN201010002270.8 | 2010-01-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011085645A1 true WO2011085645A1 (fr) | 2011-07-21 |
Family
ID=42472291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2011/000075 WO2011085645A1 (fr) | 2010-01-18 | 2011-01-18 | Solution de sucralose et son procédé de fabrication |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101744216A (fr) |
WO (1) | WO2011085645A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2461842T3 (es) * | 2010-12-16 | 2014-05-21 | Purac Biochem Bv | Método para la inhibición de la actividad de levadura |
CN102524644A (zh) * | 2012-01-18 | 2012-07-04 | 常州市牛塘化工厂有限公司 | 一种液体三氯蔗糖 |
CN105707833A (zh) * | 2016-03-07 | 2016-06-29 | 李云军 | 一种高甜度蔗糖素 |
CN107373289A (zh) * | 2017-08-02 | 2017-11-24 | 太仓市荣德生物技术研究所 | 一种使用上安全高效的生物防腐剂 |
CN109043468A (zh) * | 2018-07-16 | 2018-12-21 | 南通市常海食品添加剂有限公司 | 一种高液态三氯蔗糖组合物及其制备方法 |
CN109673919A (zh) * | 2018-12-04 | 2019-04-26 | 杭州富特名食品科技有限公司 | 六偏磷酸钠增强ε-聚赖氨酸或其盐酸盐抑菌性的应用 |
CN111458495A (zh) * | 2020-04-07 | 2020-07-28 | 上海雄图生物科技有限公司 | 一种用于时间分辨荧光免疫层析抗体标记试剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5384311A (en) * | 1990-12-14 | 1995-01-24 | Mcneil-Ppc, Inc. | Liquid concentrate compositions |
CN101120768A (zh) * | 2007-09-07 | 2008-02-13 | 苏州苏克瑞甜品科技有限公司 | 一种液体甜味剂及其制备方法 |
US20080299277A1 (en) * | 2007-06-01 | 2008-12-04 | Yaohai Chao | Sweetening Compositions |
CN101411462A (zh) * | 2007-10-15 | 2009-04-22 | 盐城捷康三氯蔗糖制造有限公司 | 三氯蔗糖水溶液及其制备方法 |
-
2010
- 2010-01-18 CN CN201010002270A patent/CN101744216A/zh active Pending
-
2011
- 2011-01-18 WO PCT/CN2011/000075 patent/WO2011085645A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5384311A (en) * | 1990-12-14 | 1995-01-24 | Mcneil-Ppc, Inc. | Liquid concentrate compositions |
US20080299277A1 (en) * | 2007-06-01 | 2008-12-04 | Yaohai Chao | Sweetening Compositions |
CN101120768A (zh) * | 2007-09-07 | 2008-02-13 | 苏州苏克瑞甜品科技有限公司 | 一种液体甜味剂及其制备方法 |
CN101411462A (zh) * | 2007-10-15 | 2009-04-22 | 盐城捷康三氯蔗糖制造有限公司 | 三氯蔗糖水溶液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101744216A (zh) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011085645A1 (fr) | Solution de sucralose et son procédé de fabrication | |
CN111698910B (zh) | 稳定化的甜菊醇糖苷组合物及其用途 | |
CA2057532C (fr) | Compositions de concentres liquides | |
TWI320697B (en) | Packaged beverages | |
RU2234945C2 (ru) | Стабилизатор водного раствора и водосодержащего сырья с самопроизвольно изменяющимися окислительно-восстановительными свойствами | |
JP4627477B2 (ja) | 酢酸又は食酢を配合したマカ抽出物含有飲食物 | |
AU2008284737B2 (en) | Chlorella extract-containing material and method of improving the storage stability thereof | |
CN107410442A (zh) | 一种肉类食品保鲜灭菌剂及其制备方法 | |
JP2008148588A (ja) | ポリフェノール組成物 | |
US20130045314A1 (en) | Liquid sucralose sweetener composition | |
WO2006022174A1 (fr) | Inhibiteur de brunissement contenant comme ingrédient actif de l’acide ascorbique 2-glucoside et procédé d’inhibition de brunissement utilisant cet inhibiteur | |
ZA200207705B (en) | Use a polyphosphate as a tooth erosion inhibitor in acidic compositions. | |
TW200520695A (en) | Packaged beverages | |
JP2008148586A (ja) | ポリフェノール組成物 | |
ES2384510T3 (es) | Bebida ácida de bacterias de ácido láctico y método para producir la bebida ácida de bacterias de ácido láctico | |
JP2008148587A (ja) | ポリフェノール組成物 | |
JP2009062301A (ja) | ヤエヤマアオキエキスおよびその利用 | |
JP4587710B2 (ja) | 抗菌剤組成物 | |
JP2010265215A (ja) | メチオニナーゼ阻害剤 | |
ES2618839T3 (es) | Agente descolonizante de Helicobacter pylori | |
JP2006333769A (ja) | 茶抽出物 | |
KR20110053021A (ko) | 구강 양치액 조성물 | |
CN114431473A (zh) | 一种高稳定性可制作酸性风味食品的低聚果糖产品 | |
JPH066049B2 (ja) | 食品保存剤 | |
CN109805241A (zh) | 一种含中草药食品防腐剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11732635 Country of ref document: EP Kind code of ref document: A1 |